5.Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan.

Masuda H; Kobayashi T; Hachiya A; Nakashima Y; Shimizu H; Nozawa T; Ogihara Y; Ito S; Takatsuki S; Katsumata N; Suzuki Y; Takenaka S; Hirono K; Kobayashi T; Suzuki H; Suganuma E; Takahashi K; Saji T

doi:10.1016/j.jpeds.2017.10.013

5.Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan.

Masuda H, Kobayashi T, Hachiya A, Nakashima Y, Shimizu H, Nozawa T, Ogihara Y, Ito S, Takatsuki S, Katsumata N, Suzuki Y, Takenaka S, Hirono K, Kobayashi T, Suzuki H, Suganuma E, Takahashi K, Saji T

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

本文言語	日本
ページ（範囲）	115-120.e3
ジャーナル	J Pediatr.
巻	-
DOI	https://doi.org/10.1016/j.jpeds.2017.10.013
出版ステータス	出版済み - 2017
外部発表	はい

文献へのアクセス

10.1016/j.jpeds.2017.10.013

引用スタイル

@article{a6066e3f253445dd8ec8faade0366e3b,

title = "5.Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan.",

author = "Masuda H and Kobayashi T and Hachiya A and Nakashima Y and Shimizu H and Nozawa T and Ogihara Y and Ito S and Takatsuki S and Katsumata N and Suzuki Y and Takenaka S and Hirono K and Kobayashi T and Suzuki H and Suganuma E and Takahashi K and Saji T",

year = "2017",

doi = "10.1016/j.jpeds.2017.10.013",

language = "日本",

volume = "-",

pages = "115--120.e3",

journal = "J Pediatr.",

}

TY - JOUR

T1 - 5.Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan.

AU - H, Masuda

AU - T, Kobayashi

AU - A, Hachiya

AU - Y, Nakashima

AU - H, Shimizu

AU - T, Nozawa

AU - Y, Ogihara

AU - S, Ito

AU - S, Takatsuki

AU - N, Katsumata

AU - Y, Suzuki

AU - S, Takenaka

AU - K, Hirono

AU - T, Kobayashi

AU - H, Suzuki

AU - E, Suganuma

AU - K, Takahashi

AU - T, Saji

PY - 2017

Y1 - 2017

U2 - 10.1016/j.jpeds.2017.10.013

DO - 10.1016/j.jpeds.2017.10.013

M3 - 学術論文

VL - -

SP - 115-120.e3

JO - J Pediatr.

JF - J Pediatr.

ER -